title: Posttransplant lymphoproliferative disease after heart transplantation on Sandimmune therapy: treatment with interferon alfa-2b and intravenous immunoglobulin.
authors.affiliation: Clinica Medica II, RCCS S. Matteo, Pavia, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Ippoliti
authors.forename: L
authors.initials: L
authors.lastname: Martinelli
authors.forename: F
authors.initials: F
authors.lastname: Lorenzutti
authors.forename: S
authors.initials: S
authors.lastname: Incardona
authors.forename: M
authors.initials: M
authors.lastname: Negri
authors.forename: P
authors.initials: P
authors.lastname: Balduzzi
authors.forename: B
authors.initials: B
authors.lastname: Rovati
authors.forename: E
authors.initials: E
authors.lastname: Ascari
authors.forename: M
authors.initials: M
authors.lastname: Viganò
mesh_terms: D015703:Antigens, CD / Q000097:blood; D015415:Biomarkers / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000097:blood; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000628:therapy; D017455:Receptors, IgE / Q000032:analysis; D015375:Receptors, Interleukin-2 / Q000032:analysis; D011994:Recombinant Proteins; D001613:beta 2-Microglobulin / Q000032:analysis
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D016756:Immunoglobulins, Intravenous; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D017455:Receptors, IgE; D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins; D001613:beta 2-Microglobulin; D016179:Granulocyte Colony-Stimulating Factor; D016572:Cyclosporine